This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Somatomedin

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Somatomedin Means in Everyday Medical Language

Somatomedin, also called insulin-like growth factor (IGF), is a protein your body makes that helps many types of cells grow and survive. It is similar in structure to insulin, the hormone that helps control blood sugar. There are two main forms: IGF-1 and IGF-2. These proteins act as growth factors, sending signals to cells to encourage growth and division. Somatomedin plays a key role in childhood growth and continues to support tissue repair and maintenance in adults.

Why Somatomedin Can Matter in Cancer Care

Some cancer cells have many receptors on their surface for IGF, called insulin-like growth factor receptors (IGF-1R). These receptors help cancer cells grow faster and avoid dying. Because of this, scientists are studying treatments that block IGF or its receptor to slow or stop cancer growth. These experimental treatments include lab-made proteins called monoclonal antibodies, such as MK-0646 and cixutumumab, which attach to the IGF-1 receptor and block its signals. These medicines are still being tested and are mainly available through clinical trials.

What Patients Might See or Hear About Somatomedin

Patients and caregivers may come across the terms somatomedin, insulin-like growth factor, IGF, or IGF-1R in medical reports, test results, treatment plans, or discussions about clinical trials. Sometimes, experimental medicines targeting IGF-1R are mentioned as possible treatment options. Because these terms are technical and have several related names, they can be confusing. It’s important to ask your care team what these terms mean in your specific case and how they relate to your diagnosis or treatment plan.

What Somatomedin Does Not Automatically Mean

Seeing somatomedin or IGF mentioned does not mean that your cancer is caused by it or that treatments blocking IGF will cure cancer. Not all cancers involve IGF, and treatments targeting IGF receptors are still experimental and not standard care. The presence of IGF or its receptor is just one factor among many that doctors consider when planning care. It’s important not to assume that seeing this term means a diagnosis or treatment decision has been made.

How to Read Somatomedin in Context and Next Steps

When you see somatomedin or related terms in your medical records or hear about them in discussions, the best step is to ask your care team what it means for you personally. They can explain if IGF or IGF-1R is relevant to your cancer type, whether any treatments targeting it are available or suitable, and what the goals and risks of such treatments might be. This glossary entry is for education only and cannot decide what is safe or appropriate for any individual. Always rely on your care team to interpret these terms in your specific situation.

Sources

Public source information used for this glossary entry includes: